Daniel Patrick O'Day insider trades: Gilead Sciences (GILD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | GILD | ↓ Sell | 30,881 | $172.57 | $5.3M | Direct | Nov 2, 2026 (0d) |
| Oct 1, 2026 | GILD | ↓ Sell | 15,000 | $147.90 | $2.2M | Direct | Oct 2, 2026 (1d) |
| Sep 1, 2026 | GILD | ↓ Sell | 15,000 | $148.64 | $2.2M | Direct | Sep 2, 2026 (1d) |
| Aug 3, 2026 | GILD | ↓ Sell | 15,000 | $130.31 | $2.0M | Direct | Aug 4, 2026 (1d) |
| Jun 1, 2026 | GILD | ↓ Sell | 15,000 | $131.46 | $2.0M | Direct | Jun 2, 2026 (1d) |
| Apr 28, 2026 | GILD | ↓ Sell | 10,000 | $129.16 | $1.3M | Direct | Apr 29, 2026 (1d) |
| Feb 27, 2026 | GILD | ↓ Sell | 10,000 | $144.79 | $1.4M | Direct | Mar 2, 2026 (3d) |
| Feb 5, 2026 | GILD | ↓ Sell | 115,640 | $150.00 | $17.3M | Direct | Feb 6, 2026 (1d) |
| Jan 28, 2026 | GILD | ↓ Sell | 10,000 | $139.89 | $1.4M | Direct | Jan 29, 2026 (1d) |
| Jan 23, 2026 | GILD | ↓ Sell | 115,640 | $135.00 | $15.6M | Direct | Jan 26, 2026 (3d) |
| Nov 28, 2025 | GILD | ↓ Sell | 10,000 | $126.54 | $1.3M | Direct | Dec 1, 2025 (3d) |
| Oct 28, 2025 | GILD | ↓ Sell | 10,000 | $119.39 | $1.2M | Direct | Oct 29, 2025 (1d) |
| Sep 29, 2025 | GILD | ↓ Sell | 10,000 | $111.66 | $1.1M | Direct | Sep 30, 2025 (1d) |
| Aug 28, 2025 | GILD | ↓ Sell | 10,000 | $113.63 | $1.1M | Direct | Aug 29, 2025 (1d) |
| Jul 28, 2025 | GILD | ↓ Sell | 10,000 | $113.94 | $1.1M | Direct | Jul 29, 2025 (1d) |
| Jun 30, 2025 | GILD | ↓ Sell | 10,000 | $110.45 | $1.1M | Direct | Jul 1, 2025 (1d) |
| May 30, 2025 | GILD | ↓ Sell | 10,000 | $110.42 | $1.1M | Direct | Jun 2, 2025 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GILD insiders
Open-market trades in the last 12 months
About Daniel Patrick O'Day's insider trades
Daniel Patrick O'Day is Chairman & CEO at Gilead Sciences (GILD). Since May 30, 2025, Daniel has reported no open-market purchases and 17 sales worth $58.9M on SEC Form 4. In the last 12 months: 11 sales ($52.1M).
Their filings also include shares withheld for taxes (29 filings), option exercises (27 filings), grants and awards (16 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GILD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.